Mental Health Disorder

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Design Therapeutics
1 program
StayOk web applicationN/A1 trial
Active Trials
NCT03213327CompletedEst. Jul 2019
Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
Vira mobile app interventionN/A1 trial
Active Trials
NCT05638516Completed73Est. May 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Novo NordiskVira mobile app intervention
Design TherapeuticsStayOk web application

Clinical Trials (2)

Total enrollment: 73 patients across 2 trials

NCT05638516Novo NordiskVira mobile app intervention

Improving Mental Health in Youth and Lowering Risk for Obesity Through a Digital Preventative Product

Start: Nov 2022Est. completion: May 202373 patients
N/ACompleted
NCT03213327Design TherapeuticsStayOk web application

StayOK - an Innovative Measuring Instrument for the Early Identification and Treatment of Psychosocial Risks

Start: Jul 2017Est. completion: Jul 2019
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space